Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11420972 Methods and compounds for treating

Patent 11420972 was granted and assigned to Gilead Sciences on August, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Gilead Sciences

0

Current Assignee

Gilead Sciences

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Adrian S. Ray0

Dorothy Agnes Theodore0

Jay P. Parrish0

Richard L. Mackman0

Date of Patent

August 23, 2022

0

Patent Application Number

168794910

Date Filed

May 20, 2020

0

Patent Citations

US Patent 10034893 5, 6-D

US Patent 10059716 Pyrrolo[1,2-f][1,2,4]triazines useful for treating respiratory syncitial virus infections

US Patent 10065958 Methods and compounds for treating Paramyxoviridae virus infections

US Patent 10251898 Methods for treating Filoviridae virus infections

US Patent 10251904 Methods for treating arenaviridae and coronaviridae virus infections

US Patent 10377761 Pyrrolo[1,2-f][1,2,4]triazines useful for treating respiratory syncitial virus infections

US Patent 10675296 Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treating viral infections

US Patent 10682368 Methods of treating feline coronavirus infections

...

Patent Primary Examiner

Jeffrey S Lundgren

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11420972 Methods and compounds for treating

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool